Moco contains a molybdenum atom coordinated to a pterin molecule. The biosynthesis of Moco is a complex, multi-step process that involves several enzymes, including MoaC. In Bacillus licheniformis, MoaC plays a role in converting precursor Z into molybdopterin.
The molybdenum cofactor is essential for the activity of various molybdoenzymes, which participate in vital metabolic processes such as nitrogen fixation, sulfur metabolism, and carbon metabolism. Therefore, MoaC is critical for these processes, and its disruption can have significant consequences for the organism.
While specific research focused solely on recombinant Bacillus licheniformis MoaC may be limited, studies on Moco biosynthesis and related enzymes in other bacteria provide valuable insights. These studies often involve genetic, biochemical, and structural analyses to elucidate the function and mechanism of MoaC and other enzymes in the pathway.
Understanding the function of MoaC and Moco biosynthesis has potential applications in various fields:
Biotechnology: Engineering Moco biosynthesis pathways in bacteria can enhance the production of Moco-dependent enzymes with industrial applications.
Medicine: Targeting Moco biosynthesis could lead to the development of new antibacterial agents.
Agriculture: Improving Moco biosynthesis in plants can enhance nutrient utilization and stress tolerance.
Because there is no specific data available regarding Recombinant Bacillus licheniformis Molybdenum cofactor biosynthesis protein C (moaC), the below table presents theoretical data based on general research principles and knowledge of similar proteins and enzymes.
| Property | Description |
|---|---|
| Molecular Weight | Estimated between 25-35 kDa. |
| Optimal pH | Assumed to be around 7.0-8.0, typical for cytoplasmic enzymes. |
| Optimal Temperature | Predicted to be between 30-45°C, consistent with the mesophilic nature of Bacillus licheniformis. |
| Metal Dependence | Binds molybdenum, which is crucial for its catalytic activity. |
| Substrates | Precursor Z (specific structure not detailed here due to limited data). |
| Products | Molybdopterin (structure available in general biochemical databases). |
| Inhibitors | Likely inhibited by Moco analogs or compounds that interfere with molybdenum binding. |
| Homologous Proteins | Exhibits sequence similarity to MoaC proteins in other bacteria. |
| Cellular Localization | Cytoplasmic, where Moco biosynthesis occurs. |
| Stability | May require specific buffer conditions (e.g., Tris-HCl, pH 7.5) and reducing agents (e.g., DTT) for in vitro stability. |
| Assay Method | Spectrophotometric assay measuring the conversion of Precursor Z to Molybdopterin. |
| Mutation Effects | Knockout mutations result in Moco deficiency and pleiotropic effects on molybdoenzyme activity. |
| Post-translational Modifications | May undergo phosphorylation or other modifications affecting its activity or stability. |
| Cofactor Interactions | Interacts with other proteins in the Moco biosynthesis pathway, such as MoaA, MoaD, and MoaE. |
Further research on Bacillus licheniformis MoaC is needed to fully elucidate its structure, function, and regulation. This includes:
Determining the crystal structure of MoaC to understand its catalytic mechanism.
Investigating the interactions of MoaC with other proteins in the Moco biosynthesis pathway.
Exploring the regulation of MoaC expression in response to environmental signals.
Developing biotechnological applications based on MoaC and Moco biosynthesis.
Function: Catalyzes the conversion of (8S)-3',8-cyclo-7,8-dihydroguanosine 5'-triphosphate to cyclic pyranopterin monophosphate (cPMP).
KEGG: bld:BLi00617
STRING: 279010.BLi00617
Molybdenum cofactor (Moco) biosynthesis protein C (MoaC) is an essential enzyme involved in the early steps of molybdenum cofactor biosynthesis. Moco serves as a critical component for enzymes such as xanthine oxidase, sulfite oxidase, and nitrate reductase, playing a fundamental role in various biological systems . The molybdenum cofactor has a tricyclic pyranopterin structure with a dithiolene moiety that coordinates a molybdenum atom. This cofactor is synthesized through an evolutionarily conserved biosynthetic pathway found across archaea, eubacteria, and eukaryotes .
The importance of MoaC lies in its participation in the first step of Moco biosynthesis. In organisms like Escherichia coli, the Moco biosynthetic pathway involves at least seven proteins, with MoaC playing a crucial role in the initial conversion steps . Understanding the structure and function of MoaC from different organisms, including Bacillus licheniformis, provides valuable insights into the conservation and specialization of this essential metabolic pathway across species.
The crystal structure studies of MoaC from various organisms reveal that it typically forms a hexamer with 32 symmetry. For instance, the MoaC from Sulfolobus tokodaii forms a hexamer arranged as a trimer of dimers with noncrystallographic 32 symmetry . Each MoaC monomer has a globular structure with an antiparallel β-sheet consisting of four β-strands and five α-helices located on the same side relative to the β-sheet . When two monomers form a dimer, their β-sheets connect to create a larger β-sheet structure.
The putative active site of MoaC is formed by highly conserved residues, which in S. tokodaii include Pro65–His68 (located in the loop between α3 and β2), Glu101–Glu103 (in α4), and from the opposing monomer of the dimer, Lys42 (in the loop between α1 and α2), Asp117 (in α4), and Lys120 (in α4) . These conserved residues create active sites located at each end of the dimer. This structural arrangement suggests a cooperative mechanism for substrate binding and catalysis, which is essential for the protein's role in Moco biosynthesis.
Recombinant expression of B. licheniformis MoaC typically employs standard molecular cloning techniques. The gene encoding MoaC is amplified from B. licheniformis genomic DNA using PCR with specific primers containing appropriate restriction sites. The amplified gene is then cloned into an expression vector, commonly pET series vectors for E. coli expression systems, which contain a strong inducible promoter and an affinity tag (such as His-tag) for purification.
For protein expression, the recombinant plasmid is transformed into an E. coli expression strain like BL21(DE3). Expression is induced by adding IPTG when the culture reaches mid-log phase, typically at an OD600 of 0.6-0.8. The expression conditions, including temperature, IPTG concentration, and induction time, are optimized to maximize soluble protein yield.
Purification generally follows a multi-step approach:
Affinity chromatography (if a His-tag is used, Ni-NTA resin)
Ion-exchange chromatography to remove contaminating proteins
Size-exclusion chromatography to obtain a homogeneous protein preparation and confirm the oligomeric state
The purity of the protein is assessed by SDS-PAGE, and its activity can be verified through enzyme assays measuring the conversion of appropriate substrates.
For example, S. tokodaii MoaC contains an additional loop formed by the insertion of seven residues (Glu126, Asn127, Gly128, Gln129, Tyr130, Pro131, and Tyr132) between α5 and β4, which participates in intermonomer interactions . This additional loop forms hydrogen-bond interactions with the opposing subunit, potentially contributing to the stability of the dimer structure. Additionally, in S. tokodaii MoaC, three residues in the N-terminal loop region (Lys5, Ile6, and Val7) adopt a β-strand conformation (β0) and form hydrogen bonds with residues in adjacent dimers, creating an extended β-sheet consisting of ten β-strands from four monomers .
These structural differences likely reflect adaptations to different environmental conditions. B. licheniformis MoaC might exhibit similar structural adaptations, particularly considering its diverse ecological niches and probiotic properties.
Several experimental approaches can be employed to elucidate the catalytic mechanism of B. licheniformis MoaC:
Site-directed mutagenesis: Based on sequence alignments with well-characterized MoaC proteins, conserved residues in the putative active site can be mutated to assess their roles in catalysis. For instance, mutations of residues corresponding to Pro65–His68, Glu101–Glu103, Lys42, Asp117, and Lys120 in S. tokodaii MoaC would provide insights into their functional importance .
Enzyme kinetics: Steady-state kinetic analyses with varying substrate concentrations can determine kinetic parameters (Km, kcat, kcat/Km) for wild-type and mutant proteins. These parameters would provide quantitative measures of the effects of mutations on substrate binding and catalysis.
Isothermal titration calorimetry (ITC): ITC can measure the thermodynamic parameters of substrate binding to MoaC, providing information about binding affinity, stoichiometry, and the enthalpy and entropy changes associated with binding.
X-ray crystallography: Determining the crystal structure of B. licheniformis MoaC in the presence of substrates, products, or substrate analogs would reveal the binding mode and potential conformational changes during catalysis. This approach was successful for S. tokodaii MoaC, which was crystallized and its structure determined at 2.2 Å resolution .
Mass spectrometry: Mass spectrometry can identify reaction intermediates and characterize post-translational modifications that might regulate MoaC activity.
Optimizing crystallization conditions for B. licheniformis MoaC requires a systematic approach:
Protein preparation: Ensure high purity (>95%) and homogeneity of the protein sample. Verify the oligomeric state using size-exclusion chromatography, as MoaC typically forms hexamers .
Initial screening: Employ commercial crystallization screens (e.g., Hampton Research, Molecular Dimensions) covering a wide range of conditions. Use techniques like sitting or hanging drop vapor diffusion to test multiple conditions simultaneously.
Optimization strategies:
Fine-tune promising conditions by varying pH, precipitant concentration, and protein concentration
Test different additives and detergents that might promote crystal formation
Try seeding techniques to promote nucleation and crystal growth
Consider surface entropy reduction by mutating surface residues with high conformational entropy to alanine
Explore crystallization with substrates, products, or inhibitors to stabilize specific conformations
Alternative approaches:
If full-length protein crystallization proves challenging, consider creating truncated constructs removing flexible regions
Co-crystallization with antibody fragments to provide additional crystal contacts
Use of fusion partners like T4 lysozyme that facilitate crystallization
For S. tokodaii MoaC, crystals were grown using the vapor diffusion method, and the structure was determined at 2.2 Å resolution . Similar approaches might be effective for B. licheniformis MoaC, potentially with adjustments to account for protein-specific properties.
B. licheniformis is recognized as a probiotic organism with beneficial effects on both humans and animals. Studies have shown that B. licheniformis supplementation can improve growth performance, intestinal mucosal barrier functions, and immunity in weaned piglets . While the direct connection between MoaC and these probiotic properties is not explicitly established in the provided search results, several hypotheses can be proposed.
Molybdenum cofactors are essential for enzymes involved in nitrogen, carbon, and sulfur metabolism. By ensuring the proper functioning of these metabolic pathways through efficient Moco biosynthesis, MoaC might indirectly contribute to:
Improved nutrient utilization: Enhanced activity of molybdoenzymes could lead to better nutrient processing, potentially explaining the improved growth performance observed in B. licheniformis-supplemented animals .
Antioxidant defense: Moco-dependent enzymes like xanthine oxidase play roles in purine metabolism and redox reactions. B. licheniformis supplementation has been shown to increase activities of antioxidant enzymes like glutathione peroxidase (GSH-Px), superoxide dismutase (SOD), and total antioxidant capacity (T-AOC) while decreasing malondialdehyde (MDA) content .
Intestinal health: B. licheniformis has been demonstrated to attenuate the negative effects of lipopolysaccharide (LPS) on intestinal morphology, particularly by reducing crypt depth and increasing villus height to crypt depth ratio in the jejunum . These effects could be partially mediated by metabolic pathways requiring Moco-dependent enzymes.
The following table summarizes the effects of B. licheniformis on serum antioxidant parameters in piglets:
| Parameter | CON | BL | LPS | BL-LPS | Statistical Significance |
|---|---|---|---|---|---|
| GSH-Px activity | Baseline | Increased | Decreased | Increased compared to LPS | P < 0.05 |
| SOD activity | Baseline | Increased | No significant change | Increased compared to LPS | P < 0.05 |
| T-AOC | Baseline | Increased | No significant change | Increased compared to LPS | P < 0.05 |
| MDA content | Baseline | Decreased | Increased | Decreased compared to LPS | P < 0.05 |
These data suggest that B. licheniformis enhances antioxidant capacity and reduces oxidative damage , which might be indirectly influenced by MoaC's role in molybdoenzyme function.
Several bioinformatic approaches can be employed to analyze the evolutionary conservation of B. licheniformis MoaC's active site:
Based on analysis of MoaC from other organisms, the putative active site residues that would likely be conserved in B. licheniformis MoaC include those corresponding to Pro65–His68, Glu101–Glu103, Lys42, Asp117, and Lys120 in S. tokodaii MoaC . These residues would be primary targets for conservation analysis and subsequent experimental validation.
Isothermal titration calorimetry (ITC) is a powerful technique for quantitatively measuring the thermodynamic parameters of biomolecular interactions. For studying substrate binding to B. licheniformis MoaC, the following optimization steps are recommended:
Sample preparation:
Ensure high purity (>95%) of both protein and substrate
Dialyze protein and substrate in the exact same buffer to minimize heat of dilution effects
Determine optimal protein concentration (typically 10-50 μM) based on expected binding affinity
Use concentration of substrate in the syringe that is 10-20 times higher than the protein concentration
Experimental parameters:
Optimize temperature (typically 25°C, but may vary depending on protein stability)
Set injection volume (2-10 μL) and spacing (180-300 seconds) to ensure return to baseline
Determine appropriate number of injections (20-30) to achieve saturation
Set appropriate reference power (5-10 μcal/sec) and stirring speed (300-400 rpm)
Controls and validations:
Perform control experiments including buffer-into-buffer, substrate-into-buffer, and buffer-into-protein
Validate results with independent methods like fluorescence spectroscopy or surface plasmon resonance
Test different buffer conditions (pH, salt concentration) to optimize signal-to-noise ratio
Data analysis:
Fit data using appropriate binding models (one-site, two-site, sequential binding)
Extract thermodynamic parameters: binding affinity (Kd), enthalpy change (ΔH), entropy change (ΔS), and stoichiometry (n)
Perform experiments at different temperatures to determine heat capacity changes (ΔCp)
This approach would provide comprehensive thermodynamic information about substrate binding to B. licheniformis MoaC, offering insights into the energetics and mechanisms of enzyme-substrate interactions.
An optimal experimental design for investigating the impact of specific mutations on B. licheniformis MoaC activity would include the following components:
Selection of mutation sites:
Target conserved residues in the putative active site based on sequence alignments with well-characterized MoaC proteins
Include residues corresponding to Pro65–His68, Glu101–Glu103, Lys42, Asp117, and Lys120 identified in S. tokodaii MoaC
Design additional mutations targeting residues involved in oligomerization, as MoaC functions as a hexamer
Mutation strategy:
Perform alanine scanning mutagenesis for initial assessment
Follow up with more conservative substitutions to probe specific chemical properties
Create double or triple mutants to assess synergistic effects
Generate chimeric proteins with corresponding regions from other MoaC proteins to assess domain-specific functions
Protein expression and purification:
Express wild-type and mutant proteins under identical conditions
Purify proteins using the same protocol to ensure comparability
Verify protein folding and oligomeric state using circular dichroism and size-exclusion chromatography
Activity assays:
Develop a robust assay for MoaC activity, potentially using coupled enzyme systems or direct detection of product formation
Determine kinetic parameters (Km, kcat, kcat/Km) for all variants
Assess substrate specificity profiles for wild-type and mutant proteins
Test activity under various conditions (pH, temperature, salt concentration) to identify condition-dependent effects
Structural characterization:
Determine crystal structures of key mutants to correlate activity changes with structural alterations
Perform molecular dynamics simulations to assess the impact of mutations on protein dynamics
Use hydrogen-deuterium exchange mass spectrometry to identify regions with altered conformational flexibility
Statistical analysis:
Perform all experiments in triplicate to ensure reproducibility
Use appropriate statistical tests (t-test, ANOVA) to assess the significance of observed differences
Apply multiple comparison corrections when comparing numerous mutants
This comprehensive approach would provide mechanistic insights into how specific residues contribute to B. licheniformis MoaC function and could guide efforts to engineer the protein for enhanced activity or altered specificity.
Two-dimensional nuclear magnetic resonance (NMR) spectroscopy offers powerful tools for studying protein dynamics at atomic resolution. For B. licheniformis MoaC, the following NMR approaches would be valuable:
Sample preparation:
Express isotopically labeled protein (15N, 13C, or both) in minimal media
For a protein the size of MoaC hexamer (~102 kDa), consider using deuteration to improve spectral quality
Optimize buffer conditions (pH, salt, temperature) for spectral quality while maintaining native structure
NMR experiments for structural analysis:
1H-15N HSQC to obtain protein "fingerprint" and assess folding
HNCA, HNCACB, CBCA(CO)NH for backbone assignments
15N-NOESY-HSQC, 13C-NOESY-HSQC for structural constraints
Transverse relaxation optimized spectroscopy (TROSY) to improve spectral resolution for the large MoaC hexamer
Dynamics measurements:
15N relaxation measurements (T1, T2, heteronuclear NOE) to characterize ps-ns timescale motions
Relaxation dispersion experiments (CPMG, R1ρ) to probe μs-ms conformational exchange
ZZ-exchange spectroscopy to detect slower conformational transitions
Ligand binding studies:
Chemical shift perturbation experiments to map binding interfaces
Transferred NOE experiments to determine bound ligand conformations
Saturation transfer difference (STD) NMR to identify ligand epitopes
Data analysis and interpretation:
Model-free analysis of relaxation data to extract order parameters and correlation times
Map dynamics data onto the protein structure to correlate with functional regions
Compare dynamics in free and substrate-bound states to identify allosteric networks
Challenges for MoaC include its large size as a hexamer, which may necessitate studying smaller oligomeric states or domains. Alternatively, selective labeling strategies or specific probes at key residues could provide targeted information about dynamics at functionally important sites.
Several challenges may arise when expressing recombinant B. licheniformis MoaC, along with potential solutions:
Protein insolubility:
Challenge: Formation of inclusion bodies
Solutions:
Lower induction temperature (16-20°C)
Reduce inducer concentration
Co-express with chaperones (GroEL/GroES, DnaK/DnaJ)
Use solubility tags (SUMO, MBP, TrxA)
Optimize growth media and induction timing
Incorrect oligomeric state:
Challenge: Failure to form the functional hexameric structure
Solutions:
Adjust buffer conditions (pH, salt concentration)
Add stabilizing agents (glycerol, specific metal ions)
Ensure proper disulfide bond formation if relevant
Consider co-expression with interaction partners
Low expression levels:
Challenge: Poor yield of target protein
Solutions:
Optimize codon usage for expression host
Test different promoters and expression vectors
Screen various E. coli expression strains
Consider alternative expression systems (Bacillus, yeast)
Protein instability:
Challenge: Rapid degradation of expressed protein
Solutions:
Add protease inhibitors during purification
Use expression strains deficient in specific proteases
Identify and modify protease-sensitive sites
Optimize storage conditions (buffer components, temperature)
Post-translational modifications:
Challenge: Incorrect or missing modifications in the expression host
Solutions:
Express in hosts capable of performing relevant modifications
Engineer the protein to eliminate modification requirements
Perform in vitro modifications after purification
By systematically addressing these challenges, researchers can optimize the expression and purification of functional B. licheniformis MoaC for subsequent structural and functional studies.
When faced with conflicting data about the structure-function relationship of B. licheniformis MoaC, researchers should adopt a systematic approach to reconciliation:
Methodological considerations:
Evaluate the reliability and limitations of each experimental technique
Consider whether different methods might be probing different aspects of protein structure or function
Assess the experimental conditions (pH, temperature, buffer components) used in conflicting studies
Examine protein constructs for differences in tags, truncations, or mutations
Structural heterogeneity:
Integration of multiple data types:
Combine structural data (X-ray crystallography, NMR, cryo-EM) with functional assays
Use computational methods (molecular dynamics, quantum mechanics/molecular mechanics) to bridge gaps between static structures and dynamic functions
Develop unified models that accommodate seemingly conflicting observations
Targeted experiments to resolve conflicts:
Design experiments specifically addressing the contradictions
Use multiple orthogonal techniques to validate key findings
Consider time-resolved methods to capture transitional states
Comparative analysis:
An example of structural differences that might lead to functional variations is seen between S. tokodaii and E. coli MoaC. S. tokodaii MoaC contains an additional loop formed by seven inserted residues that participate in intermonomer interactions, potentially contributing to the stability of the dimer structure . Such structural variations could explain functional differences observed between MoaC proteins from different organisms.
Several promising research directions for B. licheniformis MoaC and its role in molybdenum cofactor biosynthesis include:
Structural biology approaches:
Determine high-resolution crystal structures of B. licheniformis MoaC in different states (apo, substrate-bound, product-bound)
Use cryo-electron microscopy to visualize the hexameric assembly and potential conformational changes during catalysis
Apply hydrogen-deuterium exchange mass spectrometry to map dynamic regions involved in substrate binding and catalysis
Systems biology integration:
Map the entire molybdenum cofactor biosynthesis pathway in B. licheniformis
Investigate regulatory mechanisms controlling MoaC expression and activity
Explore metabolic flux through the Moco biosynthesis pathway under different growth conditions
Comparative studies:
Compare B. licheniformis MoaC with MoaC proteins from other probiotics to identify unique features
Investigate how MoaC has evolved across diverse bacteria, particularly those adapted to different ecological niches
Examine the relationship between MoaC variations and the metabolic versatility of different bacterial species
Connection to probiotic properties:
Investigate how MoaC-dependent molybdoenzymes contribute to the beneficial effects of B. licheniformis in the host gut
Study whether MoaC activity correlates with antioxidant capacity and other probiotic benefits observed in B. licheniformis supplementation
Develop B. licheniformis strains with modified MoaC to enhance specific probiotic properties
Technological applications:
Explore the potential use of B. licheniformis MoaC for in vitro synthesis of molybdenum cofactors
Investigate applications in bioremediation, as molybdoenzymes often participate in the transformation of environmental pollutants
Develop biosensors based on molybdoenzymes dependent on MoaC activity
These research directions would advance our understanding of molybdenum cofactor biosynthesis in B. licheniformis and potentially reveal connections to its probiotic properties, opening new avenues for applications in both basic science and biotechnology.